These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26995595)

  • 1. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.
    Jacobson CA; Freedman AS
    Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
    Trotman J; Cheah CY; Marlton P; Opat S
    Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.
    Reagan PM; Friedberg JW
    Curr Treat Options Oncol; 2015 Jul; 16(7):32. PubMed ID: 26031546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain.
    Sabater E; López-Guillermo A; Rueda A; Salar A; Oyagüez I; Collar JM
    Appl Health Econ Health Policy; 2016 Aug; 14(4):465-477. PubMed ID: 27090915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk follicular lymphoma: Treatment options.
    Kahl B
    Hematol Oncol; 2021 Jun; 39 Suppl 1():94-99. PubMed ID: 34105813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase III open-label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine-rituximab in treatment-naïve follicular lymphoma.
    Paikaray SK; Gogia A; Kumar L; Sharma A; Biswas AA; Vishnubhatla S; Mallick S
    Indian J Cancer; 2023 Oct; 60(4):501-504. PubMed ID: 38185869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies.
    Nabhan C; Smith SM; Kahl BS
    Leuk Lymphoma; 2012 May; 53(5):770-8. PubMed ID: 21958083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standard treatment and future perspectives for follicular lymphoma].
    Kameoka Y
    Rinsho Ketsueki; 2022; 63(9):1135-1144. PubMed ID: 36198539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine-Rituximab.
    Rajabto W; Harahap AS; Putra HN
    Acta Med Indones; 2024 Apr; 56(2):249-252. PubMed ID: 39010773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pros and cons of rituximab maintenance in follicular lymphoma.
    Zhang L; Ghielmini M; Cheson BD; Ujjani C
    Cancer Treat Rev; 2017 Jul; 58():34-40. PubMed ID: 28628883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low grade lymphoma: research progress and questions about treatment].
    Ishizawa K
    Rinsho Ketsueki; 2015 Oct; 56(10):2039-46. PubMed ID: 26458443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?
    Forstpointner R; Dreyling M
    Curr Hematol Malig Rep; 2011 Dec; 6(4):207-15. PubMed ID: 21909660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma.
    Freeman CL; Kridel R; Moccia AA; Savage KJ; Villa DR; Scott DW; Gerrie AS; Ferguson D; Cafferty F; Slack GW; Farinha P; Skinnider B; Connors JM; Sehn LH
    Blood; 2019 Aug; 134(9):761-764. PubMed ID: 31300404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
    Cohen Y; Solal-Céligny P; Polliack A
    Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular lymphoma.
    Ghielmini M
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii151-3. PubMed ID: 20943608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.
    Pettengell R; Schmitz N; Gisselbrecht C; Smith G; Patton WN; Metzner B; Caballero D; Tilly H; Walewski JA; Bence-Bruckler I; To B; Geisler CH; Schots R; Kimby E; Taverna CJ; Kozák T; Dreger P; Uddin R; Ruiz de Elvira C; Goldstone AH
    J Clin Oncol; 2013 May; 31(13):1624-30. PubMed ID: 23547078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced-stage III/IV follicular lymphoma: treatment strategies for individual patients.
    Heinzelmann F; Ottinger H; Engelhard M; Soekler M; Bamberg M; Weinmann M
    Strahlenther Onkol; 2010 May; 186(5):247-54. PubMed ID: 20437015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of follicular lymphoma.
    Izutsu K
    J Clin Exp Hematop; 2014; 54(1):31-7. PubMed ID: 24942944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular lymphoma: emerging therapeutic strategies.
    Kenkre VP; Kahl BS
    Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.
    Vidal L; Gafter-Gvili A; Salles G; Bousseta S; Oberman B; Rubin C; van Oers MH; Fortpied C; Ghielmini M; Pettengell R; Witzens-Harig M; Dreger P; Vitolo U; Gomes da Silva M; Evangelista A; Li H; Freedman L; Habermann TM; Shpilberg O
    Eur J Cancer; 2017 May; 76():216-225. PubMed ID: 28336303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.